NCT06628791View on ClinicalTrials.gov

BK329 and Body Fat Reduction

NAEnrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

December 31, 2025

Conditions
Obesity and Overweight
Interventions
DIETARY_SUPPLEMENT

BK329

Lactococcus lactics. subsp. lactis CAB701(KCCM13360P) 400 mg/day for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo 400 mg/day for 12 weeks

Trial Locations (1)

50612

Pusan National University Yangsan Hospital, Yangsan

All Listed Sponsors
lead

Pusan National University Yangsan Hospital

OTHER